Breaking News Instant updates and real-time market news.

IFRX

InflaRx

$30.33

0.94 (3.20%)

, CCXI

ChemoCentryx

$13.60

0.31 (2.33%)

08:07
07/13/18
07/13
08:07
07/13/18
08:07

InflaRx initiated with an Outperform at BMO Capital

As reported earlier, BMO Capital analyst Matthew Luchini initiated InflaRX (IFRX) with an Outperform rating and a price target of $45. The analyst notes that the company's IFX-1 "could be a best-in-class treatment for hidradenitis suppurativa" skin diseas, with initial data suggesting a "better clinical profile" than Humira. Luchini adds that the strength of IFX-1's Phase IIa data de-risks the ongoing Phase IIb trial, also stating that "IFX-1's targeting of C5a could be an advantage over emerging competitor avacopan" made by ChemoCentryx (CCXI).

IFRX

InflaRx

$30.33

0.94 (3.20%)

CCXI

ChemoCentryx

$13.60

0.31 (2.33%)

IFRX InflaRx
$30.33

0.94 (3.20%)

06/28/18
RHCO
06/28/18
INITIATION
Target $55
RHCO
Buy
InflaRx initiated with a Buy at SunTrust
SunTrust analyst Yatin Suneja initiated InflaRx with a Buy and $55 price target.
06/28/18
RAJA
06/28/18
INITIATION
Target $44
RAJA
Outperform
InflaRx initiated with an Outperform at Raymond James
Raymond James analyst Steven Seedhouse initiated InflaRx with an Outperform and $44 price target.
06/28/18
RHCO
06/28/18
INITIATION
Target $55
RHCO
Buy
InflaRx initiated with a Buy at SunTrust
As reported earlier, SunTrust analyst Yatin Suneja initiated InflaRx with a Buy rating and a price target of $55. The analyst says the company's only clinical candidate IFX-1 has produced "promising Phase 2a data in hidradenitis suppurativa skin disease", adding that he is optimistic about the program's success in the Phase 2b trial which is expected to yield initial data in the first half of FY19. Suneja believes that IFX-1 could achieve peak global sales of about $2B.
07/13/18
BMOC
07/13/18
INITIATION
Target $45
BMOC
Outperform
InflaRx initiated with an Outperform at BMO Capital
BMO Capital analyst Matthew Luchini initiated InflaRx with an Outperform and $45 price target.
CCXI ChemoCentryx
$13.60

0.31 (2.33%)

08/10/17
JMPS
08/10/17
NO CHANGE
JMPS
ChemoCentryx should be bought on weakness, says JMP Securities
JMP Securities analyst Michael G. King says that the 22% plunge in ChemoCentryx's stock has created a buying opportunity. The analyst says that the company had a number of "positive clinical developments," including "patient enrollment progress in the company's Phase III ADVOCATE trial for avacopan in patients with ANCA-Associated Vasculitis , as well as planned launches for avacopan and CCX140 in complement C3 glomerulopathy and focal segmental glomerulosclerosis, respectively." The analyst expects the company's clinical program to create value, and he reiterates a $13 price target and an Outperform rating on the shares.
05/02/18
HCWC
05/02/18
INITIATION
Target $20
HCWC
Buy
ChemoCentryx initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Edward White started ChemoCentryx with a Buy rating and $20 price target. The analyst sees "multiple value-generating earlier-stage assets within the pipeline."
05/16/18
ADAM
05/16/18
INITIATION
Target $17
ADAM
Buy
ChemoCentryx initiated with a Buy at Canaccord
Canaccord analyst Michelle Gilson initiated ChemoCentryx with a Buy rating. The analyst views data from two Phase 2 studies evaluating avacopan as supportive of the company's ongoing Phase 3 study in ANCA-associated vasculitis, boding well for the mid-2019 readout on non-inferiority. She said the pipeline provides upside opportunity as the case study of a patient demonstrating benefit two years out is encouraging. Gilson has a $17 price target on ChemoCentryx shares.
06/28/18
RAJA
06/28/18
INITIATION
Target $18
RAJA
Strong Buy
ChemoCentryx initiated with a Strong Buy at Raymond James
Raymond James analyst Steven Seedhouse initiated ChemoCentryx with a Strong Buy and $18 price target.

TODAY'S FREE FLY STORIES

HMNY

Helios and Matheson

$0.02

0.0001 (0.58%)

10:33
10/15/18
10/15
10:33
10/15/18
10:33
Hot Stocks
Helios and Matheson: Proxy firms recommend voting for reverse stock split »

Helios and Matheson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
10/15/18
10/15
10:30
10/15/18
10:30
Conference/Events
RBC Capital healthcare tech analyst to hold analyst/industry conference call »

Healthcare Technology…

PFE

Pfizer

$43.13

-0.65 (-1.48%)

10:30
10/15/18
10/15
10:30
10/15/18
10:30
Options
Pfizer call option buyers as shares slip »

Pfizer call option buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

  • 07

    Nov

10:30
10/15/18
10/15
10:30
10/15/18
10:30
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

CAMP

CalAmp

$19.42

-0.02 (-0.10%)

, EB

Eventbrite

$27.95

-0.17 (-0.60%)

10:29
10/15/18
10/15
10:29
10/15/18
10:29
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

CAMP

CalAmp

$19.42

-0.02 (-0.10%)

EB

Eventbrite

$27.95

-0.17 (-0.60%)

XYF

X Financial

$9.10

-0.45 (-4.71%)

BSVN

Bank7

$18.47

0.35 (1.93%)

ELAN

Elanco

$31.90

-0.76 (-2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

PH

Parker-Hannifin

$163.81

-3.6 (-2.15%)

, ROK

Rockwell Automation

$170.00

-2.89 (-1.67%)

10:29
10/15/18
10/15
10:29
10/15/18
10:29
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

PH

Parker-Hannifin

$163.81

-3.6 (-2.15%)

ROK

Rockwell Automation

$170.00

-2.89 (-1.67%)

NTRI

Nutrisystem

$34.46

-2.66 (-7.17%)

KLAC

KLA-Tencor

$91.27

-1.91 (-2.05%)

DLPH

Delphi Technologies

$23.27

-0.09 (-0.39%)

MNST

Monster Beverage

$52.46

-0.83 (-1.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$164.45

0.63 (0.38%)

, PNC

PNC Financial

$124.75

0.6 (0.48%)

10:29
10/15/18
10/15
10:29
10/15/18
10:29
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

MCD

McDonald's

$164.45

0.63 (0.38%)

PNC

PNC Financial

$124.75

0.6 (0.48%)

RL

Ralph Lauren

$124.99

3.5 (2.88%)

ATVI

Activision Blizzard

$75.00

-2.99 (-3.83%)

LULU

Lululemon

$144.33

0.63 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 23

    Oct

  • 06

    Nov

  • 16

    Jan

  • 12

    Apr

  • 17

    Jul

  • 16

    Oct

HMLP

Hoegh LNG Partners

$17.82

0.155 (0.88%)

10:29
10/15/18
10/15
10:29
10/15/18
10:29
Hot Stocks
Breaking Hot Stocks news story on Hoegh LNG Partners 

Hoegh LNG trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$332.99

5.51 (1.68%)

10:26
10/15/18
10/15
10:26
10/15/18
10:26
Periodicals
Lockheed Martin's F-35 flights resume after examination, Reuters reports »

F-35 jets have resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 30

    Oct

AMZN

Amazon.com

$1,747.72

-40.91 (-2.29%)

10:26
10/15/18
10/15
10:26
10/15/18
10:26
Technical Analysis
Technical Take: Amazon.com poised for a bounce »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 25

    Oct

NBEV

New Age Beverages

$6.62

0.43 (6.95%)

10:25
10/15/18
10/15
10:25
10/15/18
10:25
Options
New Age Beverages call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
10/15/18
10/15
10:25
10/15/18
10:25
Conference/Events
Cowen pharmaceuticals analyst to hold an analyst/industry conference call »

Pharmaceuticals Analyst…

IHRT

iHeartMedia

$0.00

(0.00%)

10:25
10/15/18
10/15
10:25
10/15/18
10:25
Conference/Events
Cowen TMT analyst Vitanza to hold an analyst/industry conference call »

Technology, Media and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

PBYI

Puma Biotechnology

$42.19

-0.5 (-1.17%)

, RHHBY

Roche

$0.00

(0.00%)

10:20
10/15/18
10/15
10:20
10/15/18
10:20
Recommendations
Puma Biotechnology, Roche analyst commentary  »

Roche breast cancer data…

PBYI

Puma Biotechnology

$42.19

-0.5 (-1.17%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 19

    Oct

  • 07

    Nov

  • 24

    Dec

10:20
10/15/18
10/15
10:20
10/15/18
10:20
General news
The 0.5% U.S. August business inventory rise »

The 0.5% U.S. August…

10:18
10/15/18
10/15
10:18
10/15/18
10:18
Hot Stocks
Breaking Hot Stocks news story  »

Mercantil Bank Holding…

AAPL

Apple

$218.56

-3.54 (-1.59%)

10:18
10/15/18
10/15
10:18
10/15/18
10:18
Technical Analysis
Technical Take: Apple near session lows »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
10/15/18
10/15
10:17
10/15/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
10/15/18
10/15
10:16
10/15/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
10/15/18
10/15
10:15
10/15/18
10:15
General news
Treasury Action: yields remained easier »

Treasury Action: yields…

10:13
10/15/18
10/15
10:13
10/15/18
10:13
Hot Stocks
Breaking Hot Stocks news story  »

Mercantil Bank Holding…

ATVI

Activision Blizzard

$74.23

-3.76 (-4.82%)

10:13
10/15/18
10/15
10:13
10/15/18
10:13
Technical Analysis
Technical Take: Activision Blizzard bounces off low of the day »

The shares were last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$192.26

0.02 (0.01%)

10:10
10/15/18
10/15
10:10
10/15/18
10:10
Options
Home Depot calls active »

Home Depot calls active.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
10/15/18
10/15
10:10
10/15/18
10:10
General news
U.S. business inventories rose 0.5% with sales up 0.5% too in August »

U.S. business inventories…

CGC

Canopy Growth

$52.89

3.1 (6.23%)

10:05
10/15/18
10/15
10:05
10/15/18
10:05
Options
Canopy Growth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.